SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (97)2/5/1997 6:09:00 PM
From: Michael Collins   of 1115
 
James, my apologies. I owned Lidak from 94 - early 96. The earliest
releases I got for them were from '93 so I never knew of the
collaboration. Funny they never provided an update or anything on
it after all these years.

Lidak's President, Dr. David Katz, is also President of the Medical
Biology Institute (MBI). MBI granted Lidak the rights to their
technology which was under development at the time of the
agreement, which includes their LMI technology as a vaccine to
treat various cancers (melanoma trial in Phase I/II). In return I
believe MBI got a bunch of shares of common stock in Lidak and
a small royalty on product sales (3-5% I think).

Sincerely,

Michael Collins
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext